US Patent Issued to ABSCI on April 29 for "Cancer associated antibody compositions and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,484, issued on April 29, was assigned to ABSCI Corp. (Vancouver, Wash.).

"Cancer associated antibody compositions and methods of use" was invented by Daniele Biasci (Cambridge, Mass.), Ines De Santiago Domingos De Jesus (Cambridge, Mass.) and Berke Cagkan Toptas (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure herein relates to novel cancer-associated antibodies that are used in the treatment and diagnosis of a cancer. The complete polypeptide and nucleic acid consensus sequences of the antibodies disclosed herein are reconstructed in silico."

The patent was filed on Sept. 19, 2019, under Application No. 17/277,214.

*...